Topics

FDA releases new draft guidance for biosimilar insulins

06:50 EST 11 Dec 2019 | SmartBrief

The FDA released new draft guidance for marketing insulin biosimilars, which may result in "a more efficient development prog -More

Original Article: FDA releases new draft guidance for biosimilar insulins

NEXT ARTICLE

More From BioPortfolio on "FDA releases new draft guidance for biosimilar insulins"

Quick Search

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...